Browse Pet Safety Reports
17,908 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 17,908 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product — widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 17,908 FDA veterinary adverse event reports for Horse.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Apr 15, 2024 | Horse | Horse (unknown) | MSK | Lack of efficacy - NOS | Outcome Unknown |
| Apr 13, 2024 | Horse | Warmblood (unspecified) | MSK | Lack of efficacy - NOS | Ongoing |
| Apr 13, 2024 | Horse | Quarter Horse | MSK | Death; Blindness; Ataxia; Falling; Necropsy performed; Septicaemia; Ulcerativ... | Died |
| Apr 13, 2024 | Horse | Quarter Horse | MSK | Injection site pain; Injection site swelling; Injection site stiffness | Ongoing |
| Apr 12, 2024 | Horse | Horse (unknown) | MSK | Lack of efficacy - NOS | Outcome Unknown |
| Apr 12, 2024 | Horse | Thoroughbred | MSK | Lack of efficacy - NOS | Recovered/Normal |
| Apr 12, 2024 | Horse | Anglo Arab | MSK | Sheath oedema; Localised pain NOS (see other SOCs for specific pain); Leucope... | Ongoing |
| Apr 12, 2024 | Horse | Arab | MSK | Oral ulceration | Outcome Unknown |
| Apr 11, 2024 | Horse | Pony (unspecified) | MSK | Lack of efficacy - NOS | Ongoing |
| Apr 11, 2024 | Horse | Horse (other) | MSK | Laminitis; Hyperthermia; Neutrophilia; Bone and joint disorder NOS; Abnormal ... | Ongoing |
| Apr 10, 2024 | Horse | Horse (other) | MSK | Application site oedema; Application site irritation; Application site skin s... | Outcome Unknown |
| Apr 10, 2024 | Horse | Irish Cob (Tinker) | MSK | Application site swelling | Recovered/Normal |
| Apr 10, 2024 | Horse | Quarter Horse | MSK | Lack of efficacy - NOS | Ongoing |
| Apr 9, 2024 | Horse | Paint | MSK | Lack of efficacy - NOS | Recovered/Normal |
| Apr 9, 2024 | Horse | Horse (unknown) | MSK | Lack of efficacy - NOS | Ongoing |
| Apr 9, 2024 | Horse | Quarter Horse | MSK | Lack of efficacy - NOS | Recovered/Normal |
| Apr 8, 2024 | Horse | Saddlebred - American | MSK | Lack of efficacy - NOS; Anorexia | Recovered/Normal |
| Apr 8, 2024 | Horse | Quarter Horse | MSK | Injection site swelling | Outcome Unknown |
| Apr 7, 2024 | Horse | Horse (unknown) | MSK | Lying down; Trembling; Unable to rise; Increased respiratory rate; Lack of re... | Recovered/Normal |
| Apr 7, 2024 | Horse | Horse (unknown) | MSK | Hypersalivation | Recovered/Normal |
| Apr 7, 2024 | Horse | Warmblood (unspecified) | MSK | Muscle wasting; Injection site hair change | Recovered with Sequela |
| Apr 5, 2024 | Horse | Horse (unknown) | MSK | Injection site swelling; Decreased appetite; Colitis; Endotoxaemia; Septicaem... | Euthanized |
| Apr 5, 2024 | Horse | Horse (unknown) | MSK | Injection site swelling; Decreased appetite; Colitis; Endotoxaemia; Septicaem... | Euthanized |
| Apr 5, 2024 | Horse | Quarter Horse | MSK | Collapse NOS (see also Cardio-vascular and Neurological disorders); Moribund;... | Euthanized |
| Apr 5, 2024 | Horse | Horse (unknown) | MSK | Anorexia | Outcome Unknown |
| Apr 5, 2024 | Horse | Quarter Horse | MSK | Abnormal adrenocorticotropic hormone (ACTH) stimulation test; Aggression; Pol... | Recovered/Normal |
| Apr 5, 2024 | Horse | Quarter Horse, Horse (unkno... | MSK | Twitching; Lying down; Increased heart rate; Head down | Recovered/Normal |
| Apr 4, 2024 | Horse | Arab | MSK | Lack of efficacy - NOS | Ongoing |
| Apr 4, 2024 | Horse | Thoroughbred | MSK | Enlarged lymph node (localised); Seroma; Alopecia local; Lethargy (see also C... | Outcome Unknown |
| Apr 4, 2024 | Horse | Horse (unknown) | MSK | Lack of efficacy - NOS | Outcome Unknown |
| Apr 4, 2024 | Horse | Quarter Horse | MSK | Injection site swelling | Recovered/Normal |
| Apr 3, 2024 | Horse | Quarter Horse | MSK | Increased sweating; Rolling; Not eating; Elevated temperature | Recovered/Normal |
| Apr 3, 2024 | Horse | Warmblood - Dutch, Welsh Po... | MSK | Injection site pain; Injection site swelling | Recovered/Normal |
| Apr 2, 2024 | Horse | Horse (other) | MSK | Not eating; Fever; Tongue disorder NOS; Behavioural disorder NOS; Lethargy (s... | Recovered/Normal |
| Apr 2, 2024 | Horse | Unknown | MSK | Application site infection; No sign | Outcome Unknown |
| Apr 2, 2024 | Horse | Thoroughbred | MSK | Fever; Swollen limb; Lameness; Warm feeling to the touch; Other abnormal test... | Outcome Unknown |
| Apr 2, 2024 | Horse | Quarter Horse | MSK | Death; Lethargy (see also Central nervous system depression in Neurological);... | Died |
| Apr 2, 2024 | Horse | Unknown | MSK | Application site swelling; No sign | Outcome Unknown |
| Apr 1, 2024 | Horse | Pony (unspecified) | MSK | Lack of efficacy - NOS | Outcome Unknown |
| Apr 1, 2024 | Horse | Horse (unknown) | MSK | General hair loss | Outcome Unknown |
| Apr 1, 2024 | Horse | Horse (unknown) | MSK | Lack of efficacy - NOS | Outcome Unknown |
| Apr 1, 2024 | Horse | Thoroughbred | MSK | Lack of efficacy (endoparasite) - strongylids | Outcome Unknown |
| Mar 29, 2024 | Horse | Paint | MSK | Lack of efficacy - NOS | Outcome Unknown |
| Mar 29, 2024 | Horse | Horse (unknown) | MSK | Lack of efficacy - NOS; Leucopenia NOS; Lymphopenia; High adrenocorticotropic... | Outcome Unknown |
| Mar 29, 2024 | Horse | Warmblood (unspecified) | MSK | Shaking; Difficulty standing; Ataxia; Anaphylaxis | Recovered/Normal |
| Mar 29, 2024 | Horse | Horse (other) | MSK | Collapse NOS (see also Cardio-vascular and Neurological disorders); Hives (se... | Recovered/Normal |
| Mar 29, 2024 | Horse | Quarter Horse | MSK | Lack of efficacy - NOS | Ongoing |
| Mar 29, 2024 | Horse | Horse (unknown) | MSK | Lack of efficacy - NOS | Outcome Unknown |
| Mar 28, 2024 | Horse | Horse (unknown) | MSK | Lack of efficacy - NOS | Recovered/Normal |
| Mar 28, 2024 | Horse | Quarter Horse | MSK | Cough; Tachypnoea; Tongue protrusion; Application site swelling; Mouth irrita... | Recovered/Normal |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe — difficulty breathing, seizures, collapse, or severe swelling — seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.